Weekly influenza update, week 17, April 2018

Data Graph Infographic Map
Period: 23 Apr 2018 - 29 Apr 2018

In collaboration with WHO Regional Office for Europe, ECDC monitors and reports on influenza activity in Europe on a weekly basis throughout the flu season.

Flu infographic week 17/2018


Flu infographic week 17/2018 - EN - [PNG-97.91 KB]


  • Influenza activity was at inter-season levels in all but one reporting country.
  • While low in number, 11% of the individuals sampled from primary healthcare settings tested positive for influenza viruses (compared to 12% in the previous week).
  • Both influenza virus types A and B were co-circulating with the majority being type A.

2017/18 season overview 

  • Influenza viruses have been circulating at high levels in the Region between weeks 52/2017 and 12/2018 (based on increased proportions - 40% and above - of sentinel specimens testing positive for influenza viruses). This is longer than in recent seasons and may have contributed to the severity of this season.
  • The majority of influenza viruses detected were type B, representing a high level of circulation of influenza B viruses compared to recent seasons. B/Yamagata lineage viruses have greatly outnumbered those of the B/Victoria lineage.
  • Different patterns of dominant type and A subtypes were observed between the countries of the Region.
  • While low in numbers, characterized A(H3N2) viruses fell mainly in clade 3C.2a (57%) and subclade 3C.2a1 (42%), while 42% of B/Victoria lineage viruses fell in a subclade of clade 1A viruses that are antigenically distinct from the current trivalent vaccine component. Click here for more information
  • The majority of severe cases reported this season were due to influenza virus type B infection and have mostly occurred in persons older than 15 years.
  • Mortality from all causes now appears be have returned to normal expected levels in all 21 participating countries and regions that report to EuroMOMO.
  • Interim results from 5 European studies indicate 25 to 52% vaccine effectiveness against any influenza. Click here for more information